Tercica
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2000 Sierra Point Pkwy Ste 400, Brisbane...Phone Number
(650) 624-4900Website
www.tercica.comRevenue
$23.8 MillionIndustry
ZI Rank: 1
About Tercica
Tercica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tercica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Tercica is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Tercica
Product Launch: Get notified when Tercica launches new products
Earning: See what the market has to say on Tercica recently announced quarterly report
Funding: Get notified immidiatlly once Tercica has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tercica had a recent Job posting/layoffs
Tercica, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Tercica has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Tercica
Find 2 more new buyers
Company Profile Activity
Activity Insights
Tercica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tercica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tercica.
Tercica Tech Stack
A closer look at the technologies used by Tercica
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tercica
Tercica is a biopharmaceutical company focused on the development and commercialization of recombinant human insulin-like growth factor-1 for the treatment of short stature and other metabolic disorders. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities i... Read More
